Analyst Ranking
Top 18%
#844 out of 4861 analysts
Average Return
+12.88%
Win Rate
63%15 out of 24
Risk vs Reward
Poor
Good

Ying Huang's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ablynx NvABLX
+153.33%$20.87$52.87
2017-11-10 -
2018-06-12
Strong Buy
Regenxbio IncRGNX
+151.02%$29.40$73.80
2017-09-21 -
2018-07-23
Strong Buy
Regenxbio IncRGNX
+128.48%$32.30$73.80
2017-10-09 -
2018-07-23
Strong Buy
Gilead Sciences IncGILD
+90.68%$33.32$63.54
2012-09-27 -
2013-09-27
Strong Buy
Audentes Therapeutics IncBOLD1
+37.86%$27.31$37.65
2017-09-22 -
2018-09-21
Strong Buy

Ying Huang's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Vertex Pharmaceuticals IncVRTX
6Strong Buy$567.00+15.93%Maintains
22 days ago
Eidos Therapeutics IncEIDX
1Hold$13.00N/AMaintains
7 years ago
Radius Health IncRDUS1
1Strong Buy$47.00N/AMaintains
7 years ago
Regenxbio IncRGNX
3Hold$80.00N/ADowngrades
7 years ago
Esperion Therapeutics IncESPR
2SellN/AN/ADowngrades
7 years ago
Q32 Bio IncQTTB
1Strong Buy$486.00N/AInitiates Coverage On
7 years ago
Cytomx Therapeutics IncCTMX
2Strong Buy$40.00N/AMaintains
7 years ago
Bluebird Bio IncBLUE
1Hold$4,360.00N/AMaintains
7 years ago
Gilead Sciences IncGILD
3Hold$87.00N/AMaintains
7 years ago
Puma Biotechnology IncPBYI
2Strong Buy$115.00N/AMaintains
7 years ago
Celgene CorpCELG
1HoldN/AN/ADowngrades
7 years ago
Ironwood Pharmaceuticals IncIRWD
1SellN/AN/ADowngrades
7 years ago
Ablynx NvABLX
1Strong Buy$26.00N/AInitiates Coverage On
7 years ago
Biogen IncBIIB
1Strong Buy$365.00N/AMaintains
8 years ago
Intercept Pharmaceuticals IncICPT
1Sell$73.00N/AMaintains
8 years ago
Audentes Therapeutics IncBOLD1
1Strong Buy$33.00N/AMaintains
8 years ago
Rein Therapeutics IncRNTX
1Strong Buy$380.00N/AInitiates Coverage On
8 years ago
Amgen IncAMGN
1Strong BuyN/AN/AUpgrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.